4//SEC Filing
Elagin Vecheslav A 4
Accession 0001127602-17-031880
CIK 0000794172other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 3:39 PM ET
Size
9.3 KB
Accession
0001127602-17-031880
Insider Transaction Report
Form 4
Elagin Vecheslav A
Sr VP, Research & Development
Transactions
- Award
Common Stock
2017-11-08+7,500→ 55,989 total - Award
Stock Options (Right to Buy)
2017-11-08+12,500→ 12,500 totalExercise: $14.65Exp: 2027-11-08→ Common Stock (12,500 underlying) - Disposition to Issuer
Common Stock
2017-11-09−10,000→ 45,989 total
Holdings
- 80(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]These restricted stock units are awarded under the 2012 Stock Incentive Plan and vest in full (100%) on November 15, 2021.
- [F2]These restricted stock units were awarded under the 2012 Stock Incentive Plan and were subject to attainment by the Company of a specified earnings target for fiscal 2017. As the Company did not reach the target, these restricted stock units have been cancelled.
- [F3]These options are granted awarded under the 2012 Stock Incentive Plan and vest in full (100%) on November 15, 2021.
Documents
Issuer
MERIDIAN BIOSCIENCE INC
CIK 0000794172
Entity typeother
Related Parties
1- filerCIK 0001307505
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 3:39 PM ET
- Size
- 9.3 KB